Toshinari Yamashita

23PUBLICATIONS
138CO-AUTHORS
Molecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 30, 2025
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.

Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem

|Oct 10, 2024
Network Analyses Applied to the Dimensions of Cancer-Related Fatigue in Women With Breast Cancer.

Louise Baussard, Marie Ernst, Anh Diep

|Sep 13, 2024
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

Nadia Harbeck, Eva Ciruelos, Guy Jerusalem

|Oct 27, 2023
Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer.

Matthew P Goetz, Erika P Hamilton, Mario Campone

|Sep 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.

Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa

|Jul 14, 2023
End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data Linkage.

Victoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster

Pageof 4

Frequent Collaborators

4 joint publications

Hans Wildiers

3 joint publications

Charlotte Grégoire

3 joint publications

Nadia Harbeck

3 joint publications

Concetta Elisa Onesti